[HTML][HTML] A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention

M Golshani, S Buozari - Iranian biomedical journal, 2017 - ncbi.nlm.nih.gov
Brucellosis caused by species of Brucella is among the most prevalent zoonoses with the
annual incidence of half a million cases globally. Most parts of Iran are endemic for …

Evaluation of brucellosis vaccines: a comprehensive review

M Heidary, S Dashtbin, R Ghanavati… - Frontiers in Veterinary …, 2022 - frontiersin.org
Brucellosis is a bacterial zoonosis caused by Brucella spp. which can lead to heavy
economic losses and severe human diseases. Thus, controlling brucellosis is very …

Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches

M Saadi, A Karkhah, HR Nouri - Infection, Genetics and Evolution, 2017 - Elsevier
Current investigations have demonstrated that a multi-epitope peptide vaccine targeting
multiple antigens could be considered as an ideal approach for prevention and treatment of …

Brucellosis: epidemiology, pathogenesis, diagnosis and treatment–a comprehensive review

KA Qureshi, A Parvez, NA Fahmy… - Annals of …, 2023 - Taylor & Francis
Background: Brucellosis is a pervasive zoonotic disease caused by various Brucella
species. It mainly affects livestock and wildlife and poses significant public health threats …

Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection

Z Sadeghi, M Fasihi-Ramandi, M Azizi… - Journal of biotechnology, 2020 - Elsevier
Brucellosis is a worldwide bacterial zoonosis disease. Live attenuated Brucella vaccines
have several drawbacks. Thus development of a safe and effective vaccine for brucellosis is …

Meta-analysis and advancement of brucellosis vaccinology

TF Carvalho, JPA Haddad, TA Paixao, RL Santos - PloS one, 2016 - journals.plos.org
Background/Objectives In spite of all the research effort for developing new vaccines against
brucellosis, it remains unclear whether these new vaccine technologies will in fact become …

Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection

A Ghasemi, M Jeddi-Tehrani, J Mautner, MH Salari… - Vaccine, 2015 - Elsevier
Brucella vaccines consisting of live attenuated Brucella strains are currently used in
livestock, but safety concerns preclude their application in humans. Subunit vaccines have …

Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization

M Abkar, AS Lotfi, J Amani, K Eskandari… - Veterinary research …, 2015 - Springer
Brucellosis is the most common zoonotic bacterial disease. Prevention of human brucellosis
is achieved through pasteurization of dairy products, appropriate sanitation and vaccination …

Comparison of Immune Effects Between Brucella Recombinant Omp10-Omp28-L7/L12 Proteins Expressed in Eukaryotic and Prokaryotic Systems

L Zhu, Q Wang, Y Wang, Y Xu, D Peng… - Frontiers in veterinary …, 2020 - frontiersin.org
Brucella, a genus of bacteria that causes brucellosis, infects and threatens domestic
animals, and humans in endemic areas. Presently, some live attenuated vaccines of …

Nanoparticle-based vaccines for brucellosis: calcium phosphate nanoparticles-adsorbed antigens induce cross protective response in mice

Z Sadeghi, M Fasihi-Ramandi… - International Journal of …, 2020 - Taylor & Francis
Introduction Vaccine formulation with appropriate adjuvants is an attractive approach to
develop protective immunity against pathogens. Calcium phosphate nanoparticles (CaPNs) …